Back
Theravance Biopharma Stock Price Chart
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
42
TBPH
Theravance Biopharma
Last Price:
9.46
Seasonality Move:
-14.12%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing slight buying pressure.
Theravance Biopharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.07 | Buy |
| 20-day SMA: | 9.29 | Buy |
| 50-day SMA: | 9.1 | Buy |
| 200-day SMA: | 9.6 | Sell |
| 8-day EMA: | 9.16 | Buy |
| 20-day EMA: | 9.18 | Buy |
| 50-day EMA: | 9.2 | Buy |
| 200-day EMA: | 9.62 | Sell |
Theravance Biopharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 54.94 | Buy |
| Chaikin Money Flow: | 4938 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.97 - 9.57) | Buy |
| Bollinger Bands (100): | (8.64 - 10.4) | Sell |
Theravance Biopharma Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theravance Biopharma Stock
Is Theravance Biopharma Stock a Buy?
- Theravance Biopharma share price is 9.46 while TBPH 8-day simple moving average is 9.07, which is a Buy signal.
- The stock price of TBPH is 9.46 while Theravance Biopharma 20-day SMA is 9.29, which makes it a Buy.
- Theravance Biopharma 50-day simple moving average is 9.10 while TBPH share price is 9.46, making it a Buy technically.
- TBPH stock price is 9.46 and Theravance Biopharma 200-day simple moving average is 9.60, creating a Sell signal.
TBPH Technical Analysis vs Fundamental Analysis
Sell
42
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy or a Sell?
-
Theravance Biopharma stock is rated a Sell
The current Theravance Biopharma [TBPH] share price is $9.46. The Score for TBPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Theravance Biopharma Stock Info
Market Cap:
455.64M
Price in USD:
9.46
Share Volume:
330.84K
Theravance Biopharma 52-Week Range
52-Week High:
11.98
52-Week Low:
8.21
Sell
42
Theravance Biopharma (TBPH)
is a Sell
Theravance Biopharma Share Price Forecast
-
What is the Theravance Biopharma stock price today?
The Theravance Biopharma stock price is 9.46 USD today. -
Will TBPH stock go up or go down?
Theravance Biopharma> share price is forecast to RISE/FALL based on technical indicators -
Is Theravance Biopharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theravance Biopharma is overvalued.
Is Theravance Biopharma Stock a Buy?
- Theravance Biopharma share price is 9.46 while TBPH 8-day exponential moving average is 9.16, which is a Buy signal.
- The stock price of TBPH is 9.46 while Theravance Biopharma 20-day EMA is 9.18, which makes it a Buy.
- Theravance Biopharma 50-day exponential moving average is 9.20 while TBPH share price is 9.46, making it a Buy technically.
- TBPH stock price is 9.46 and Theravance Biopharma 200-day simple moving average is 9.62, creating a Sell signal.
Fundamental Analysis of Theravance Biopharma
Is Theravance Biopharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.
Technical Analysis of Theravance Biopharma
Should I short Theravance Biopharma stock?
- TBPH Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Theravance Biopharma is a Sell
- Theravance Biopharma Relative Strength Index (RSI) is 54.94, which suggest Theravance Biopharma is overbought
- The Bollinger Bands (25) for Theravance Biopharma is (8.97 - 9.57), which suggest Theravance Biopharma is a Sell
- The Bollinger Bands (100) for Theravance Biopharma is (8.64 - 10.4), which suggest Theravance Biopharma is a Sell
* Theravance Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.